Skip to main content

and
Your search also matched 15 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

The role of systemic inflammatory response index (SIRI) and tumor-infiltrating lymphocytes (TILs) in the prognosis of patients with laryngeal squamous cell carcinoma

Include preview-only content
  1. Article

    Open Access

    Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study

    Recently, progression-free survival at 24 months (PFS24) was defined as clinically relevant for patients with extranodal NK/T cell lymphoma. Herein, the clinical data from two independent random cohorts (696 p...

    Jia-Ying Li, **ao-Rong Hou, Si-Ye Chen, **n Liu, Qiu-Zi Zhong in Annals of Hematology (2023)

  2. Article

    Open Access

    Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia

    Acute promyelocytic leukemia (APL) has become curable over 95% patients under a complete chemo-free treatment with all-trans retinoic acid (ATRA) and arsenic trioxide in low-risk patients. Minimizing chemother...

    Ya-Fang Ma, Ying Lu, Qian Wu, Yin-Jun Lou, Min Yang in Journal of Hematology & Oncology (2022)

  3. Article

    Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study

    Yong Yang, Ying Wang, **n Liu, **a He, Li-Ling Zhang, Gang Wu, Bao-Lin Qu in Leukemia (2021)

  4. Article

    Open Access

    Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study

    Limited evidence supports the use of early endpoints to evaluate the success of initial treatment of extranodal NK/T-cell lymphoma (ENKTCL) in the modern era. We aim to analyze progression-free survival at 24 ...

    Yong Yang, Ying Wang, **n Liu, **a He, Li-Ling Zhang, Gang Wu, Bao-Lin Qu in Leukemia (2021)

  5. Article

    Open Access

    Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making

    Derived from our original nomogram study by using the risk variables from multivariable analyses in the derivation cohort of 1383 patients with extranodal NK/T-cell lymphoma, nasal-type (ENKTCL) who were mostl...

    Si-Ye Chen, Yong Yang, Shu-Nan Qi, Ying Wang, Chen Hu, **a He, Li-Ling Zhang in Leukemia (2021)

  6. Article

    Open Access

    RNA sequencing: new technologies and applications in cancer research

    Over the past few decades, RNA sequencing has significantly progressed, becoming a paramount approach for transcriptome profiling. The revolution from bulk RNA sequencing to single-molecular, single-cell and s...

    Mingye Hong, Shuang Tao, Ling Zhang, Li-Ting Diao in Journal of Hematology & Oncology (2020)

  7. Article

    Open Access

    Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma

    Extranodal natural killer T-cell lymphoma (nasal type; NKTCL) is an aggressive malignancy strongly associated with Epstein-Barr virus (EBV) infection. However, the role of EBV in NKTCL development is unclear, ...

    Rou-Jun Peng, Bo-Wei Han, Qing-Qing Cai, **ao-Yu Zuo, Tao **a, Jie-Rong Chen in Leukemia (2019)